Category Archives: Wherein

Board construction of “wherein” clause affirmed; remanded for review of non-instituted grounds

Alere, Inc. v. Rembrandt Diagnostics, LP Docket Nos. 2018-1812 (IPR2016-01502) NEWMAN, DYK, REYNA October 29, 2019 Non-Precedential Brief Summary: Board’s claim construction of the “wherein” clause affirmed; decision remanded for consideration of non-instituted grounds. Summary: Alere appealed Board IPR final … Continue reading

Posted in Claim Construction, Functional limitations, Inter Parties Review (IPR), IPR, Obviousness, Uncategorized, Wherein | Leave a comment

DC decision affirmed as safety and efficacy “wherein” clauses are limiting

Allergan, Inc. et al. v. Sandoz, Inc., Alcon Laboratories Docket No. 2018-2207 PROST, NEWMAN, WALLACH August 29, 2019 Brief Summary: DC grant of a preliminary injunction to Allergan affirmed since the “wherein” clauses relating to safety and efficacy were found … Continue reading

Posted in Claim Construction, Uncategorized, Wherein | Leave a comment